policy
ACAP Comments on NCQA Proposed Changes to HEDIS MY 2026
On March 13, ACAP issued its comments on the NCQA proposed changes to HEDIS MY 2026.
The letter shares:
Support for:
- Proposed Removal – Asthma Medication Ratio (AMR)
Support with modification or concern for:
- Proposed Addition – Tobacco Use Screening and Cessation Intervention (TSC-E)
- Proposed Addition – Follow-up After Acute Care Visits for Asthma (AAF-E)
- Proposed Revision – Social Needs Screening and Intervention (SNS-E)
- Proposed Revision – Lead Screening in Children (LSC)
- Proposed Revision – Follow-up After High-Intensity Care for Substance Use Disorder (FUI)
- Proposed Revision – Statin Therapy for Patients with Cardiovascular Disease (SPC)
- Proposed Revision – Statin Therapy for Patients with Diabetes (SPD)
- Cross-Cutting Item – Alignment with Updated Federal Standards for Race and Ethnicity
No support for:
- Proposed Addition – Disability Description of Membership (DDM)
- Proposed Revision – Adult Immunization Status (AIS-E)
Read the letter in full, including detailed comments, via the sidebar to the right.